drugset / Trial / NCT03937661
Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders
Phase 2/3
Recruiting
100 enrolled
Genesis Athens Clinic
National and Kapodistrian University of Athens · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Autologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).
Timeline
- Start
- 2019-05-06
- Primary completion
- 2027-01-30
- Completion
- 2028-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | Other |